Influence of febuxostat and Topiroxostat on renal function

Trial Profile

Influence of febuxostat and Topiroxostat on renal function

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Febuxostat (Primary) ; Topiroxostat (Primary)
  • Indications Hyperuricaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2016 Planned number of patients changed from 40 to 50.
    • 25 Aug 2016 Status changed from recruiting to completed.
    • 10 Apr 2016 Planned number of patients changed from 60 to 40.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top